The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly expands access to millions of commercially insured patients, improving availability of life-saving allergy ...

HERCESSI™ becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...

ST. LOUIS, April 12, 2018 /PRNewswire/ -- Guided by the principles of simplification, choice, and competition, Express Scripts (NASDAQ: ESRX) today announced the launch of a new, innovative 12-month ...

Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA® ...

FT. LAUDERDALE, Fla., December 02, 2025--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it’s TRUE METRIX ® Self-Monitoring Blood Glucose Systems are preferred for commercial patients on ...

Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meters and Test Strips on the Express Scripts Commercial National Preferred Formulary Providing accurate and ...